Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. M. C. Neukamm, H. Arne Didrik, S. Vidar, O. Torbjørn (Lørenskog, Norway). Increased prevalence of elevated high-sensitivity cardiac troponin T among patients with stable chronic obstructive pulmonary disease. Eur Respir J 2011; 38: Suppl. 55, 1016

Member's Comments

No comment yet.

Related content which might interest you: Predictors of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 The effects of elevated troponin I on long-term mortality after chronic obstructive pulmonary disease exacerbation Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation Source: Eur Respir J 2008; 31: 563-570 Year: 2008 Cardiac troponin T levels increase overnight in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Troponin T elevation and one year mortality after acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009 Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 High-sensitive troponin T as a new biomarker and an indicator of disease severity in patients with pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Exercise induced elevation of high-sensitive troponin T serum levels in patients with pulmonary hypertension Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Genetically elevated C-reactive protein and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Environmental and genetic risk factors for asthma and COPD Year: 2009 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Serum amyloid A in patients with stable chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 363s Year: 2007 Acute exacerbation of COPD is associated with three-fold elevation of cardiac troponin T Source: Annual Congress 2012 - Acute exacerbation in COPD Year: 2012 Serum magnesium levels of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006